Simon Blankley

3.0k citations
23 papers · 2.2k · 5 hit papers · h-index 18

Impact in

Papers in

    • Tuberculosis Research and Epidemiology 6
    • SARS-CoV-2 and COVID-19 Research 3
    • Immune Response and Inflammation 4
    • interferon and immune responses 3
    • Immunodeficiency and Autoimmune Disorders 1

Simon Blankley

23 papers receiving 2.1k citations

Simon Blankley's Hit Papers

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial 2022 · 282 citations
2820+1+3Years since publication100200300400

Peers

Simon Blankley
Comparison fields: 5 of 112
  • Infectious Diseases 1.3k
  • Applied Microbiology and Biotechnology 53
  • Neurology 352
  • Internal Medicine 56
  • Obstetrics and Gynecology 89
Replace Susan Liebeschuetz with:
Susan Liebeschuetz United Kingdom
Laura Harrison United States
Irene Man United Kingdom
Mary-Anne C. Morris United Kingdom
Paul Fleming United Kingdom
Danyal Jajbhay United Kingdom
Muhammad S. Ahmed United Kingdom
Sally Batham United Kingdom
Stephen P. Brearey United Kingdom
Emily L. Lowe United States
Simon Blankley relative to Susan Liebeschuetz United Kingdom Susan Liebeschuetz's profile →
Citations per field
00.5×2×4×5.4×
Susan Liebeschuetz · 1×
Citations per year

Countries citing papers authored by Simon Blankley

Since Specialization
Citations

This map shows the geographic impact of Simon Blankley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon Blankley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon Blankley more than expected).

Fields of papers citing papers by Simon Blankley

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon Blankley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon Blankley. The network helps show where Simon Blankley may publish in the future.

Co-authors

The 25 scholars most cited alongside Simon Blankley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Simon Blankley Line = papers co-authored together Simon Blankley links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021403
2
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Hit paper breakdown →
2021381
3
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2022282
4
Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis
Hit paper breakdown →
2022230
5
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Hit paper breakdown →
2021211
6 2018128
7 202383
8 201680
9 201467
10 201262
11 201646
12 201237
13 201636
14 201335
15 202324
16 202423
17 201821
18 201520
19 201912
20 201411

About Simon Blankley

Simon Blankley is a scholar working on Infectious Diseases, Immunology, Epidemiology, Surgery and Cancer Research, having authored 23 papers that have together received 2.2k indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (6 papers), Immune Response and Inflammation (4 papers), interferon and immune responses (3 papers), SARS-CoV-2 and COVID-19 Research (3 papers), Mycobacterium research and diagnosis (3 papers), Diagnosis and treatment of tuberculosis (2 papers), Immunodeficiency and Autoimmune Disorders (1 paper) and Burkholderia infections and melioidosis (1 paper). The work is most often cited by research in Infectious Diseases (1.3k citations), Applied Microbiology and Biotechnology (53 citations), Neurology (352 citations), Internal Medicine (56 citations) and Obstetrics and Gynecology (89 citations). Simon Blankley has collaborated with scholars based in United Kingdom, United States and Qatar. Frequent co-authors include Anne O’Garra, Christine M. Graham, Matthew Paul Reddoch Berry, Chloë I. Bloom, Marc C.I. Lipman, Jonathan M. Pitt, Helen McShane, Damien Chaussabel, Jacques Banchereau and George Santis. Their work appears in journals such as The Lancet, PLoS ONE, The Journal of Immunology, The Lancet Child & Adolescent Health and The Lancet Diabetes & Endocrinology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact